Travis Hunter should have his name called early, but Will Johnson and Jahdae Barron are also projected first-rounders.

NFL Draft could very well be the turning point for the Indianapolis Colts. As quarterback Anthony Richardson heads into his ...

I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in the U.S.

ADRs came under pressure in the premarket on Thursday after the company announced its decision to halt a clinical program ...

The supervisory board of the Company has reviewed the financial statements 2024 on April 2nd, 2025 and the Company's ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Towards the end of 2024, Barcelona lost four of seven matches in La Liga. Their season was in freefall — but now they are ...

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

Former IPL winner Ambati Rayudu has shared his insights on Mumbai Indians (MI) IPL campaign so far and what they could do to ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 10.67%, which has investors questioning if this is right time ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...